课题基金 / 基金详情

DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet Nam

DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet Nam
DRIVE(越南的吸毒和血源性感染):联合预防和护理,结束越南海防注射吸毒者中的艾滋病毒流行
批准号:
9925208
负责人:
Don C Des Jarlais
金额:
$86.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2024-05-31

项目摘要

项目成果

Don C Des Jarlais的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Injection drug use is driving HIV epidemics in low/middle-income countries in Eastern Europe, Central Asia and Southeast Asia. "Combined prevention and care" for (including needle/syringe programs (NSP), medication- assisted treatment, and antiretroviral treatment), has greatly reduced HIV incidence among persons who inject drugs (PWID) in many high-income areas, to where the "HIV epidemics" among PWID have "ended." There is now the need for a convincing demonstration that an HIV epidemic can be ended in a low/middle income setting. The overarching purpose of the proposed research is to demonstrate that high coverage implementation of combined prevention and care using an innovative approach will end the HIV epidemic among PWID in Haiphong, Viet Nam. The innovative approach consists of i) implementing repeated large community-based respondent driven sampling (RDS) surveys to reach and test a large proportion of PWID for HIV, and ii) mobilizing peer support groups to educate about the benefits of early ART, link HIV-infected PWID into HIV care and achieve viral suppression. Peer groups will also support safer injection, safer sex, and accessing methadone treatment for both HIV positive and negative persons. The research has five specific aims: 1. Demonstrate that the innovative approach can reduce PWID population viral load (the percentage of PWID with detectable HIV viral load) by at least half. 2. Assess progress towards ending the epidemic, using direct measurement of HIV incidence among PWID. The goal is to achieve an incidence of 0.5/100 PY or less (our operational definition of "ending the epidemic'"). 3. Utilize mathematical modeling to assess the contributions of different components of combined prevention and care to ending the epidemic among PWID in Haiphong. A model previously used in several other countries will be adapted to the Haiphong setting. 4. Assess the cost-effectiveness and cost savings of the proposed intervention activities to end the HIV epidemic among PWID in Haiphong. 5. Develop a large, high retention cohort of HIV+ and HIV- PWID for future collaborative research studies. Questionnaire data and biological samples from participants in the proposed study will be stored. We expect to have approximately 1500 active participants in the cohort at the end of the proposed research period. The feasibility of this ambitious proposal is ensured by i) the 2-year DRIVE-IN feasibility study we have already conducted in Haiphong, which assessed the situation and successfully piloted the intervention, ii) The existing good facilities for HIV care and MAT, iii) the strong local commitment of political and health authorities, pre-existing peer-support groups and NGOs, and iv) the DRIVE research consortium of Vietnamese, French and US researchers, a highly qualified team with a proven record of productive collaboration.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.drugpo.2020.102913
发表时间: 2021-01
期刊: The International journal on drug policy
影响因子: --
作者: [Thu Trang N, Jauffret-Roustide M, Minh Giang L, Visier L]
通讯作者: Visier L
DOI: 10.1097/qad.0000000000002680
发表时间: 2020-11-01
期刊: AIDS (London, England)
影响因子: --
作者: [Feelemyer J, Arasteh K, Huong DT, Oanh KTH, Khue PM, Giang HT, Thanh NTT, Moles JP, Vinh VH, Vallo R, Quillet C, Rapoud D, Le SM, Michel L, Laureillard D, Nagot N, Des Jarlais DC, DRIVE STUDY TEAM]
通讯作者: DRIVE STUDY TEAM
DOI: 10.3390/jcm10214824
发表时间: 2021-10-20
期刊: Journal of clinical medicine
影响因子: 3.9
作者: [Durand M, Nagot N, Nhu QBT, Vallo R, Thuy LLT, Duong HT, Thanh BN, Rapoud D, Quillet C, Tran HT, Michel L, Tuyet TNT, Hai OKT, Hai VV, Feelemyer J, Perre PV, Jarlais DD, Minh KP, Laureillard D, Molès JP]
通讯作者: Molès JP
DOI: 10.1371/journal.pone.0259983
发表时间: 2021
期刊: PloS one
影响因子: 3.7
作者: [Des Jarlais DC, Arasteh K, Huong DT, Oanh KTH, Feelemyer JP, Khue PM, Giang HT, Thanh NTT, Vinh VH, Le SM, Vallo R, Quillet C, Rapoud D, Michel L, Laureillard D, Moles JP, Nagot N, DRIVE Study Team]
通讯作者: DRIVE Study Team
12
    Combined prevention to reduce initiation into injecting drug use
    • 批准号:
      9752913
    • 项目类别:
    • 资助金额:
      $79.25万
    • 财政年份:
      2015
    • 负责人:
      Don C Des Jarlais
    • 依托单位:
    Multiple HIV Prevention Packages for IDUs in Estonia
    Multiple HIV Prevention Packages for IDUs in Estonia
    Multiple HIV Prevention Packages for IDUs in Estonia
    国内基金
    海外基金
    层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
    • 批准号:
      2021JJ40433
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2021
    • 负责人:
      孙磊
    • 依托单位:
    寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
    • 批准号:
      32001603
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      段真珍
    • 依托单位:
    AREA国际经济模型的移植.改进和应用
    • 批准号:
      18870435
    • 项目类别:
      面上项目
    • 资助金额:
      2.0万元
    • 批准年份:
      1988
    • 负责人:
      史树中
    • 依托单位: